APA (7th ed.) Citation

Šiarnik, P., Rádiková, Ž., Kollár, B., Kutšálová, M., Penesová, A., Havranová, A., . . . Turčáni, P. (2026). Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial. Neurology & Therapy, 15(4), 2139. https://doi.org/10.1007/s40120-026-00982-4

Chicago Style (17th ed.) Citation

Šiarnik, Pavel, et al. "Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial." Neurology & Therapy 15, no. 4 (2026): 2139. https://doi.org/10.1007/s40120-026-00982-4.

MLA (9th ed.) Citation

Šiarnik, Pavel, et al. "Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial." Neurology & Therapy, vol. 15, no. 4, 2026, p. 2139, https://doi.org/10.1007/s40120-026-00982-4.